Piper Sandler Maintains Overweight on InspireMD, Raises Price Target to $4.5
InspireMD Analyst Ratings
Piper Sandler Remains a Buy on InspireMD (NSPR)
Alliance Global Adjusts Price Target on InspireMD to $4.75 From $5.15, Maintains Buy Rating
National Alliance Securities Maintains Buy on InspireMD, Lowers Price Target to $4.75
Alliance Global Partners Maintains Buy on InspireMD, Lowers Price Target to $5.15